Evidence-Based Anticoagulation Choice for Acute Pulmonary Embolism.
作者信息
Maughan Brandon C, Kabrhel Christopher, Jarman Angela F
机构信息
Department of Emergency Medicine, Oregon Health and Science University, Portland.
Center for Vascular Emergencies, Department of Emergency Medicine, Mass General Brigham, Boston.
出版信息
JAMA Netw Open. 2025 Jan 2;8(1):e2452850. doi: 10.1001/jamanetworkopen.2024.52850.
Abstract
摘要
相似文献
1
Evidence-Based Anticoagulation Choice for Acute Pulmonary Embolism.急性肺栓塞的循证抗凝治疗选择
JAMA Netw Open. 2025 Jan 2;8(1):e2452850. doi: 10.1001/jamanetworkopen.2024.52850.
2
Stopping anticoagulation for isolated or incidental subsegmental pulmonary embolism: the challenges and lessons from the STOPAPE RCT.孤立性或偶发性亚段肺栓塞抗凝治疗的停用：STOPAPE随机对照试验的挑战与经验教训
Health Technol Assess. 2025 Apr;29(11):1-12. doi: 10.3310/UGHF6892.
3
Stopping anticoagulation for isolated or incidental pulmonary embolism: the STOPAPE RCT protocol.孤立性或偶发性肺栓塞抗凝治疗的停用：STOPAPE随机对照试验方案
Health Technol Assess. 2024 Jun;29(11):1-17. doi: 10.3310/HRCW7937.
4
Treatment of Right Heart Thrombi Associated with Acute Pulmonary Embolism.急性肺栓塞相关右心血栓的治疗
Am J Med. 2017 May;130(5):588-595. doi: 10.1016/j.amjmed.2016.11.027. Epub 2016 Dec 21.
5
Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone on risk of recurrent pulmonary embolism: a randomized clinical trial.可回收下腔静脉滤器联合抗凝与单纯抗凝对复发性肺栓塞风险的影响：一项随机临床试验。
JAMA. 2015 Apr 28;313(16):1627-35. doi: 10.1001/jama.2015.3780.
6
[Anticoagulation after an acute pulmonary embolism].[急性肺栓塞后的抗凝治疗]
Presse Med. 2017 Jul-Aug;46(7-8 Pt 1):728-738. doi: 10.1016/j.lpm.2017.06.015. Epub 2017 Jul 26.
7
Persistent Risk of Pulmonary Embolism in Acute Pancreatitis Despite Prophylactic Anticoagulation.尽管进行了预防性抗凝治疗，急性胰腺炎患者仍存在肺栓塞的持续风险。
Cureus. 2024 Nov 22;16(11):e74249. doi: 10.7759/cureus.74249. eCollection 2024 Nov.
8
Outcomes after withholding anticoagulation from patients with suspected acute pulmonary embolism and negative computed tomographic findings: a cohort study.疑似急性肺栓塞且计算机断层扫描结果为阴性的患者停用抗凝治疗后的结局：一项队列研究。
Mayo Clin Proc. 2002 Feb;77(2):130-8. doi: 10.4065/77.2.130.
9
The Clot Thickens: Diagnosing Acute Pulmonary Embolism as a Trigger for Chronic Obstructive Pulmonary Disease Exacerbation in the Setting of Anticoagulation Failure.血栓形成：在抗凝治疗失败的情况下，将急性肺栓塞诊断为慢性阻塞性肺疾病加重的诱因
Eur J Case Rep Intern Med. 2020 Sep 23;7(12):001884. doi: 10.12890/2020_001884. eCollection 2020.
10
Impact of Pulmonary Embolism Response Team on Anticoagulation Prescribing Patterns in Patients With Acute Pulmonary Embolism.肺栓塞反应团队对急性肺栓塞患者抗凝治疗方案的影响。
J Pharm Pract. 2022 Feb;35(1):38-43. doi: 10.1177/0897190020940125. Epub 2020 Jul 15.
引用本文的文献
1
Hemodynamic improvement with Impella RP in acute massive pulmonary embolism: a narrative review of cardiovascular outcomes and pulmonary catheter pressure assessment.Impella RP用于急性大面积肺栓塞的血流动力学改善：心血管结局及肺动脉导管压力评估的叙述性综述
Ann Med Surg (Lond). 2025 May 26;87(7):4303-4309. doi: 10.1097/MS9.0000000000003431. eCollection 2025 Jul.
本文引用的文献
1
Factors in Initial Anticoagulation Choice in Hospitalized Patients With Pulmonary Embolism.住院肺栓塞患者初始抗凝治疗选择的影响因素
JAMA Netw Open. 2025 Jan 2;8(1):e2452877. doi: 10.1001/jamanetworkopen.2024.52877.
2
Trends in Initial Anticoagulation Among US Patients Hospitalized With Acute Pulmonary Embolism 2011-2020.2011-2020 年美国急性肺栓塞住院患者初始抗凝治疗趋势。
Ann Emerg Med. 2024 Nov;84(5):518-529. doi: 10.1016/j.annemergmed.2024.05.009. Epub 2024 Jun 18.
3
Percutaneous treatment options for acute pulmonary embolism: a clinical consensus statement by the ESC Working Group on Pulmonary Circulation and Right Ventricular Function and the European Association of Percutaneous Cardiovascular Interventions.经皮治疗急性肺栓塞的选择：ESC 肺循环和右心室功能工作组和欧洲经皮心血管介入协会的临床共识声明。
EuroIntervention. 2022 Oct 7;18(8):e623-e638. doi: 10.4244/EIJ-D-22-00246.
4
Contemporary Catheter-Based Treatment Options for Management of Acute Pulmonary Embolism.当代基于导管的急性肺栓塞治疗选择
Curr Treat Options Cardiovasc Med. 2021;23(7):44. doi: 10.1007/s11936-021-00920-7. Epub 2021 May 12.
5
Analysis of Partial Thromboplastin Times in Patients With Pulmonary Embolism During the First 48 Hours of Anticoagulation With Unfractionated Heparin.分析普通肝素抗凝治疗肺栓塞患者前 48 小时部分凝血活酶时间。
Acad Emerg Med. 2020 Feb;27(2):117-127. doi: 10.1111/acem.13872. Epub 2019 Nov 24.
6
2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS).2019年欧洲心脏病学会（ESC）与欧洲呼吸学会（ERS）合作制定的急性肺栓塞诊断和管理指南。
Eur Heart J. 2020 Jan 21;41(4):543-603. doi: 10.1093/eurheartj/ehz405.
7
Diagnosis, Treatment and Follow Up of Acute Pulmonary Embolism: Consensus Practice from the PERT Consortium.急性肺栓塞的诊断、治疗和随访：PERT 联盟的共识实践。
Clin Appl Thromb Hemost. 2019 Jan-Dec;25:1076029619853037. doi: 10.1177/1076029619853037.
8
American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy.美国血液学会 2018 年静脉血栓栓塞症管理指南：抗凝治疗的最佳管理。
Blood Adv. 2018 Nov 27;2(22):3257-3291. doi: 10.1182/bloodadvances.2018024893.
9
Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial treatment of venous thromboembolism.固定剂量皮下注射低分子量肝素与调整剂量普通肝素用于静脉血栓栓塞症的初始治疗
Cochrane Database Syst Rev. 2017 Feb 9;2(2):CD001100. doi: 10.1002/14651858.CD001100.pub4.
10
Pharmacology of anticoagulants used in the treatment of venous thromboembolism.用于治疗静脉血栓栓塞的抗凝剂的药理学。
J Thromb Thrombolysis. 2016 Jan;41(1):15-31. doi: 10.1007/s11239-015-1314-3.
Zotero 插件